Michael Callaghan

Associate Professor of Pediatrics, Director of The Cooley & Whitten Center for Hemoglobinopathies
Central Michigan University SOM, Children’s Hospital of Michigan

Presentation(s):

• VPB1189 - ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors, with or without Prophylactic Treatment

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM